Location History:
- Middlesex County, MA (US) (1985)
- Cambridge, MA (US) (1984 - 1986)
- Watertown, MA (US) (1988)
- Beverly, MA (US) (1988 - 1998)
Company Filing History:
15 out of 127 
1 out of 2,663 
Years Active: 1984-1998
Title: Walter C. Herlihy: An Innovator in Glycan-Binding Protein Research
Introduction
Walter C. Herlihy, based in Cambridge, MA, is an accomplished inventor with a remarkable portfolio of 15 patents. His innovative work focuses on glycan-binding proteins and their interactions, contributing significantly to the field of biochemistry.
Latest Patents
Among Herlihy's most notable recent patents is his work on "Analogs for specific oligosaccharide-protein interactions and uses." This patent outlines methods for identifying sequences that exhibit binding specificity for glycan-binding proteins, thus enhancing our understanding of biological activities related to these interactions. Additionally, he developed compositions and methods for creating protein-specific glycosaminoglycan sequence analogs, which have therapeutic implications.
Another significant patent is related to the "Immobilized immunoglobulin-binding proteins." This invention addresses the need for high-capacity binding materials for immunoglobulins. Specifically, it describes materials made by covalently joining an immobilization support to an arginine-containing linker and an immunoglobulin-binding protein, demonstrating utility in purifying monoclonal antibodies.
Career Highlights
Throughout his career, Walter C. Herlihy worked with prominent companies including Repligen Corporation and The Gillette Company. His contributions to these organizations reflect his strong background in biochemistry and the application of innovative technologies in real-world scenarios.
Collaborations
Walter's work has also seen him collaborate with notable colleagues such as Thomas H. Fraser and Albert T. Profy. Their combined expertise has furthered the development of groundbreaking research in the field of glycan-binding proteins.
Conclusion
Walter C. Herlihy continues to be a pivotal figure in the study of glycan-binding proteins, with his patents representing a significant advancement in therapeutic applications. His contributions not only enhance our understanding of biochemical interactions but also pave the way for future innovations in the medical and pharmaceutical fields.